Fármacos antirreumáticos modificadores de la enfermedad
DMARDS
Revisado por pares por Dr Hayley Willacy, FRCGP Última actualización por Dr Colin Tidy, MRCGPÚltima actualización 19 Nov 2022
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Agregar a fuentes preferidas en Google
En esta serie:Artritis reumatoideMedicamentos biológicos para la artritis reumatoideArtritis idiopática juvenil
Los fármacos antirreumáticos modificadores de la enfermedad (FAME) son medicamentos que normalmente se prescriben tan pronto como se diagnostica la artritis reumatoide (AR), con el fin de reducir el daño a las articulaciones. Rara vez, pueden tener efectos secundarios graves que afectan la sangre, el hígado o los riñones. Los FAME generalmente se toman por el resto de su vida. Debido a que se toman durante mucho tiempo, es necesario realizarse análisis de sangre regulares para ver si los FAME están teniendo algún efecto secundario.
De un vistazo
DMARDs are medicines for rheumatoid arthritis that ease symptoms and reduce joint damage.
They work by blocking chemicals involved in joint inflammation.
DMARDs are prescribed early after diagnosis to prevent joint damage and slow disease progression.
It can take several weeks or months for DMARDs to start working.
Regular blood tests are needed to monitor for serious side-effects.
You should not take DMARDs if you are pregnant, breastfeeding, or have severe organ problems or infections.
Report any suspected side-effects through the Yellow Card Scheme.

¿Inseguro sobre mezclar medicamentos?
Verifica posibles interacciones entre medicamentos, suplementos y alimentos antes de tomarlos juntos.
What are DMARDs: disease-modifying antirheumatic drugs?
Disease-modifying antirheumatic drugs (DMARDs) are a group of medicines that are used to ease the symptoms of artritis reumatoide (AR) and reduce the damaging effect of the disease on the joints.
There are quite a few DMARDs available to treat RA. They include:
They come in various different brand names.
There is a group of newer medicines called biological therapies which can also be used to treat RA. Like DMARDs they have a disease-modifying effect against RA and are sometimes called cytokine modulators or monoclonal antibodies. Biological therapies include adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, anakinra, abatacept, rituximab and tocilizumab. Biological therapies are not discussed further in this leaflet. See the separate leaflet called Biological medicines for rheumatoid arthritis.
DMARDs are also used to treat other conditions - for example, chronic inflammatory skin or bowel disease. However, the rest of this leaflet is only about DMARDs when they are used to treat RA.
¿Qué es la artritis reumatoide?
Arthritis means inflammation of joints. Rheumatoid arthritis (RA) is a common form of arthritis. The main symptoms are pain and stiffness of affected joints.
RA is thought to be an autoimmune disease. The immune system normally makes small proteins (antibodies) to attack bacteria, viruses, and other germs.
In people with autoimmune diseases, the immune system makes antibodies against tissues of the body. It is not clear why this happens.
In people with RA, antibodies are formed against the tissue that surrounds joints (the synovium). This causes inflammation in and around affected joints.
Over time this can damage the joint, the cartilage, and parts of the bone near the joint.
The most commonly affected joints are the small joints of the fingers, thumbs, wrists, feet and ankles.
For more information see the separate leaflet called Rheumatoid arthritis.
How do DMARDs work?
We are still not sure exactly how DMARDs work. But it is thought that they work by blocking the way inflammation develops in the joints, by blocking certain chemicals involved in the inflammation process.
When are DMARDs usually prescribed?
DMARDs are prescribed as soon as possible after RA has been diagnosed, by doctors who specialise in treating RA. Most people with RA have flare-ups followed by better spells. During these flare-ups some damage may be done to the joints. If DMARDs are taken in the early stages of RA they can prevent joint damage and help to slow down the progression of the disease.
Which DMARDs are usually prescribed?
One of methotrexate, leflunomide, or sulfasalazine is the DMARD often chosen for initial treatment. However, the choice of medicine will depend on many issues about you and your illness. Your specialist will discuss the choices, so you have the medicine best suited for you.
When choosing a DMARD your doctor will talk to you about the differences between them and look for any reasons why you may not be able to take one over another. Some people are only prescribed one DMARD; others try several before one or more can be found to suit. Your doctor will advise if it is better for you to take one or two DMARDs.
How quickly do DMARDs work?
It can take several weeks or months for DMARDs to ease the pain and inflammation caused by RA. Therefore, in addition, other medicines are normally advised for a time to help control symptoms until DMARDs start working. These may be steroid medicines, anti-inflammatory medicines and/or other painkillers.
Esteroides, anti-inflammatory medicines y analgésicos ease the pain and reduce inflammation of RA. Anti-inflammatory medicines and painkillers do not provide the benefits that DMARDS give of preventing joint damage and slowing down the disease progression. Steroids can prevent joint damage if they are given in low doses and taken over a long period of time. However, they are not usually prescribed this way anymore. If a DMARD does not work after six months then your doctor will normally change your treatment.
Methotrexate, sulfasalazine, intramuscular gold and penicillamine are all thought to work as well as each other. However, in general, methotrexate and sulfasalazine are better tolerated and have less serious side-effects.
DMARDs side-effects
It is not possible to list all the adverse effects of each DMARD in this leaflet. However, as with all medicines, there are a number of side-effects that have been reported with each of the DMARDs, some of which are serious. Serious side-effects are rare, but include damage to the liver and blood-producing cells. For more detail see the information leaflet that came with your medicine.
You must talk to your doctor or pharmacist if you develop:
A sore throat, unexplained bruising, or mouth ulcers (signs of a problem with your blood).
Also, you must talk to your doctor or pharmacist if you develop any of the following:
Una sensación de malestar (náuseas).
Estar enfermo (vómitos).
Tummy (abdominal) discomfort.
Yellowing of your skin or the whites of your eyes (jaundice).
Dark urine (signs of a problem with your liver).
Also, DMARDs sometimes react with other medicines that you may take. So, make sure your doctor knows of any other medicines that you are taking, including ones that you have bought rather than been prescribed.
Consulte el prospecto que acompaña a su marca particular para obtener una lista completa de posibles efectos secundarios y precauciones.
How often should I have blood tests when taking a disease-modifying antirheumatic drug?
Because these medicines are usually taken for a long time and they can have serious side-effects, it is usual to have regular tests - usually blood tests - whilst you take them. The tests look for some possible side-effects before they become serious.
Before DMARDs are started
Blood tests are always taken before you start treatment with a DMARD. This is to see if your liver, kidneys and blood are normal. If there are any problems, your doctor will talk to you about this. Blood tests help your doctor decide which DMARD is best for you or if another type of treatment is better for you.
After DMARDs are started
In the first six months of treatment blood tests are taken often. How often you have a blood test depends upon which DMARD you are taking. Your doctor will advise. For example, at first it can be every two to four weeks. After six months, if you have no problems, blood tests may then be taken every three months.
What will happen if my blood tests are not normal?
If there is a problem with your blood test you will usually be asked to stop taking the DMARD. Your GP will need to discuss the results of your blood test with the specialist to see what treatment you may need. In most people, once the medicine is stopped the blood, liver or kidneys return to normal.
Length of treatment
If DMARDs work well, it is usual to take one or more DMARDs for the rest of your life. When your RA is well controlled, your doctor may advise you to lower the dose (very slowly). This is in order for you to take the lowest dose and to keep the disease under control.
Can I buy DMARDs?
No. They are only available from your pharmacist, with a doctor's prescription.
Who cannot take DMARDs?
It is not possible in this leaflet to list every type of condition or type of person who cannot take each DMARD. However, in general, doctors do not prescribe DMARDs if you:
Are pregnant or breastfeeding.
Have severe liver or kidney problems.
Have a severe blood disorder.
Have a serious infection.
Have an immunodeficiency syndrome.

¿Inseguro sobre mezclar medicamentos?
Verifica posibles interacciones entre medicamentos, suplementos y alimentos antes de tomarlos juntos.
Selecciones del paciente para Bone and muscle medicines

Tratamiento y medicación
Bisfosfonatos
Bisphosphonates are a group of medicines used to treat conditions that affect your bones. Different bisphosphonates are available for different conditions.
por el Dr. Colin Tidy, MRCGP

Tratamiento y medicación
Inyecciones de esteroides
Steroid injections can be used for joint problems and rheumatoid arthritis. They can also be used for some conditions affecting soft tissues, like tendon inflammation or tennis elbow. Steroid injections can be very effective but should be used with other treatments. There is also some evidence that steroid injections may be either completely ineffective or effective for just a relatively short period of time. Other treatments may include medicines for pain relief and physiotherapy, depending on the underlying condition. The side-effects from steroid injections are uncommon. However, the injected area may be sore for the first few days after the injection.
por la Dra. Hayley Willacy, FRCGP
Preguntas frecuentes
What is the primary difference between DMARDs and biological therapies?
DMARDs and biological therapies both modify the disease and are used to treat rheumatoid arthritis. Biological therapies are a newer group of medicines, sometimes referred to as cytokine modulators or monoclonal antibodies, but they essentially serve a similar disease-modifying role to DMARDs.
Other than rheumatoid arthritis, what other conditions can DMARDs treat?
DMARDs are also effective in treating other conditions, such as chronic inflammatory skin diseases or inflammatory bowel diseases.
If my blood tests are abnormal, what is the usual outcome?
If an issue is detected with your blood test, you will typically be advised to stop taking the DMARD. Your GP will then discuss the results with a specialist to determine the next steps for your treatment. In most cases, once the medicine is stopped, the blood, liver, or kidneys return to their normal state.
Can I stop taking DMARDs if my rheumatoid arthritis is under control?
If DMARDs are working effectively and your rheumatoid arthritis is well controlled, it is common to continue taking one or more DMARDs for the rest of your life. Your doctor might gradually reduce the dose to find the lowest effective amount needed to keep the disease under control.
How do I report a side-effect from my DMARD?
You can report any suspected side-effects from your medication through the Yellow Card Scheme, which can be accessed online at www.mhra.gov.uk/yellowcard. When reporting, it's helpful to have information about the side-effect, the name of the medicine, details of the person who experienced it, and your contact information.
Lecturas adicionales y referencias
- Formulario Nacional Británico (BNF); Servicios de Evidencia NICE (acceso solo en el Reino Unido)
- Ledingham J, Gullick N, Irving K, et al; BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479.
- Artritis reumatoide en adultos: manejo; Guía NICE (julio 2018 - última actualización octubre 2020)
- DMARDs; NICE CKS, diciembre 2023 (acceso solo en el Reino Unido)
Sobre el autor

Jenny Whitehall
BSc (Hons), Diploma in Pharmacy Practice
Acerca del revisorVer biografía completa

Dr Hayley Willacy, FRCGP
Médico General, Autor Médico
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
La Dra. Hayley Willacy fue una médica general del NHS que trabajaba en el noroeste de Inglaterra, quien se retiró de la práctica clínica en 2022 después de 30 años.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
Artículo también disponible en Inglés, Alemán, Español, Francés, Italiano, Portugués, Hindi, Hebreo, Árabe, y Sueco.
Próxima revisión: 7 de octubre de 2027
19 Nov 2022 | Última versión
15 Dec 2011 | Publicado originalmente
Escrito por:
Jenny Whitehall

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Más sobre tratamiento y medicación
- Vacuna 6 en 1
- Tratamientos para el acné
- Medicamentos antitiroideos
- Fibrilación auricular y prevención de accidentes cerebrovasculares
- Terapia cognitivo-conductual
- Alergia a medicamentos
- Betalactamasas de espectro extendido
- Tratamiento y prevención de piojos
- Inhaladores para EPOC
- vacunación MMR
- Mucolíticos
- Relajantes musculares
- Broncodilatadores orales
- Fisioterapeutas
- Polio y vacuna contra la polio
- Polifarmacia
- Diuréticos ahorradores de potasio
- Probióticos y prebióticos
- Autoreferencia
- Vacuna contra la encefalitis transmitida por garrapatas